Collegium Pharmaceutical, Inc. (COLL) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Collegium Pharmaceutical, Inc. (COLL) closed at USD 22.51 on 2026-10-14, a change of -36.4 % over the past year, with a market capitalization of USD 754.64M.

Collegium Pharmaceutical, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Collegium Pharmaceutical, Inc. key figures

Previous close

USD 22.51 (2026-10-14)

1-year change

-36.4 %

Market cap

USD 754.64M

Enterprise value

USD 1.84B

P/E ratio (trailing)

16.92

P/E ratio (forward)

3.19

EPS (trailing)

1.37

EPS (forward)

7.26

PEG ratio

0.67

Price to book

2.42

Revenue growth

6.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.86

Employees

423

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Collegium Pharmaceutical, Inc. and compare it with other stocks.